Dr. Boris Arbit, MD

Dr. Arbit practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Arbit's NPI, 1003195686, was assigned on August 12, 2011. Dr. Arbit graduated from Geisel School Of Medicine At Dartmouth in 2011. Dr. Arbit holds California license A124357.

Dr. Arbit's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Arbit's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Arbit is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Arbit to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arbit practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Arbit's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Arbit is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Arbit is licensed in California.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Arbit treats.

CMS data shows 5,675 Medicare services from Dr. Arbit across 21 procedure codes in 2024, for 1,638 Medicare patients. Medicare paid $361,645 for them.

CMS counts 1,638 Medicare patients who saw Dr. Arbit in 2024. The largest group is 65 to 74, with 629 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arbit's median patient age at 64, with 49% women.

In 2024, Dr. Arbit wrote 7,845 Medicare Part D claims for 818 patients. 81% of them were for generic drugs. CMS names the drug for 7,545 of them, across 74 drugs with 11 or more claims each, at $1,328,642 in total drug cost. In 2023, CMS named 6,585 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Arbit for performance year 2024, reported as part of a group. Dr. Arbit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arbit as offering telehealth.

Dmand AI links 9 papers to Dr. Arbit, published from 2011 to 2017. 2016 was the busiest year, with 3. The most frequent topics are Heart Failure, Cause of Death and Drug Therapy, Combination. Dr. Arbit has published most often in Int J Cardiol. Dr. Arbit's most frequent co-authors are Alan Maisel, MD, Kay-Won Chang and Jonathan Chong Hsu, MD.

CMS Open Payments shows 7 general payments to Dr. Arbit from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $144.

Dr. Arbit graduated from Geisel School Of Medicine At Dartmouth in 2011.

Dr. Arbit is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.